Surgeon General's Call to Action
On September 15, 2008, the U.S. Surgeon General joined with the National Heart Lung and Blood Institute to issue a national Call to Action to highlight the negative impact of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and the Post-Thrombotic Syndrome (PTS) upon public health and to emphasize the need for new research to address these challenges. The study of new image-guided blood clot removal treatments (those being studied in the ATTRACT Study) to prevent PTS was specifically listed as an important research priority.

Click below to view The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. See Section IV (page 30) for the reference to blood clot removal treatments.



On July 28, 2009, we were honored to welcome Assistant U.S. Surgeon General Robert M. Galloway to St. Louis for the kickoff ATTRACT Study Investigator Meeting. In his keynote address, Dr. Galloway highlighted the importance of the study to U.S. public health and provided a strong endorsement, announcing
“The Surgeon General is passionate for the ATTRACT Trial to go forward.”

Reference
1. The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. U.S. Department of Health and Human Services report, 2008.